RxDoctor Payments Data

Reza Ronaghi, MD

Pulmonary Disease · Santa Monica, CANPI 1326305541

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (51.4%), speaking fees and grants — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 86.2% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $188,294, more than ten times the $4,437 reported in 2019. Among pulmonary disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$389,962in general payments, 2019–2025

Across 353 payments — averaging $1104.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$336K
  • Boston Scientific$31K
  • Pulmonx Corporation$14K
  • Covidien LP$3K
  • Cook Incorporated$2K
  • Fujifilm Healthcare Americas Corporation$2K
  • plus $2K from 4 others

What the payments were for

  • Consulting fees$15,4614%
  • Speaking & faculty fees$113,50029%
  • Grants$29,8388%
  • Travel & lodging$17,2954%
  • Food & beverage$13,6173%
  • Education$200,25051%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$389,962 in reported general payments places this provider in the 95th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Medicare billing

Part B allowed, 2024
$185,725
Medicare patients
421
Services billed
1,442

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Breo ElliptaFluticasone/Vilanterol25$9,517
Albuterol Sulfate HfaAlbuterol Sulfate39$845
Prednisone26$100
Azithromycin12$54

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →